Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 May 16;23(6):1055–1066. doi: 10.1158/1055-9965.EPI-13-0939

Table 3.

Cross correlations between changes in biomarkersa

COTΔ1 COTΔ2 NICΔ1 NICΔ2 NNALΔ1 NNALΔ2 2HPMAΔ1 3HPMAΔ1 AAMAΔ1 CNEMAΔ1 MHBMAΔ1 HEMAΔ1 PMAΔ1
COTΔ1 l 0.90*** 0.19 0.44*** 0.73*** 0.75*** –0.04 0.29* 0.74*** 0.84*** 0.10 0.65*** 0.92***
COTΔ2 1 0.09 0.51*** 0.71*** 0.78*** –0.08 0.23 0.73*** 0.86*** 0.09 0.67*** 0.92***
NICΔ1 1 0.52*** 0.09 0.12 –0.17 0.18 0.06 0.08 0.06 0.23 0.01
NICΔ2 1 0.59*** 0.66*** –0.01 0.42** 0.53*** 0.43*** 0.09 0.31* 0.35**
NNALΔ1 1 0.94*** 0.34** 0.36** 0.76*** 0.70*** 0.08 0.33* 0.64***
NNALΔ2 1 0.09 0.42** 0.86*** 0.79*** 0.10 0.44*** 0.69***
2HPMAΔ1 1 –0.10 –0.03 –0.13 –0.07 –0.34* –0.10
3HPMAΔ1 1 0.27* 0.24 0.16 0.24 0.35**
AAMAΔ1 1 0.85*** 0.09 0.45*** 0.68***
CNEMAΔ1 1 0.12 0.64*** 0.82***
MHBMAΔ1 1 0.30* 0.14
HEMAΔ1 1 0.70***
PMAΔ1 1
a

All subjects included in the analysis; COT = cotinine; NIC = nicotine; NNAL = 4–(methylritrosamino)–1–(3–pyridyl)–1–butanol; VOC mercapturic acid metabolites (parent compound in parenthesis): 2HPMA=2-hydroxypropyl (propylene oxide), 3-HPMA=3-hydroxypropyl (acrolein), AAMA=2-carbamoylethyl (acrylamide), CNEMA=cyanoethyl (acrylonitrile), MHBMA=2-hydroxy-3-buten-1-yl or isomer(s) (1,3-butadiene), HEMA=2-hydroxyethyl (ethylene oxide), and PMA=phenyl (benzene);

Δ1 = post minus pre-exposure; Δ2 = nextday minus pre-exposure; VOC mercapturic acid metabolites were only measured in pre-exposure and post-exposure samples;

*

p < 0.05

**

p < 0.01

***

p < 0.001